Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum
Public ClinicalTrials.gov record NCT03971643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Exploratory Phase IIa Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Patients With Pyoderma Gangrenosum (OPTIMA)
Study identification
- NCT ID
- NCT03971643
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- InflaRx GmbH
- Industry
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Interventions
- vilobelimab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2019
- Primary completion
- Jan 2, 2022
- Completion
- Jan 2, 2022
- Last update posted
- Sep 13, 2023
2019 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| InflaRx Site #07 | Sacramento | California | 95816 | — |
| InflaRx Site #08 | Miami | Florida | 33125 | — |
| InflaRx Site #03 | Tampa | Florida | 33613 | — |
| InflaRx Site #10 | St Louis | Missouri | 63110 | — |
| InflaRx Site #05 | Columbus | Ohio | 43210 | — |
| InflaRx Site #12 | Hershey | Pennsylvania | 17033 | — |
| InflaRx Site #09 | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03971643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2023 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03971643 live on ClinicalTrials.gov.